Chemo Revenue The Chemotherapy Drug Industry
The National Institutes of Health estimated the overall costs of cancer in 2010 at $263.8 billion, of which $102.8 billion was for direct medical costs (total of all health expenditures), $20.9 billion for loss of productivity due to illness and $140.1 billion for cost of lost productivity due to premature death. By 2017, direct medical costs had risen to an estimated 147.3 billion. One industry analyst put the size of the global chemotherapy market at $97 billion in 2017. The analysis group EvaluatePharma estimated total oncology sales in 2018 is $123.8 billion (out of a total prescription medicine market of $864 billion).